Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada approves AMDL's cancer blood test:

This article was originally published in Clinica

Executive Summary

Theranostics company AMDL has gained the go-ahead to market its cancer blood test, DR-70, in Canada. The test can detect up to 13 cancers using a single tube of blood, reducing the need for costly, multiple tests, says the Tustin, California firm. "Already, several potential distributors have shown serious interest in the Canadian market and AMDL can now accelerate those discussions," said Gary Dreher, the company's president and CEO.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064563

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel